Real-Time EquityWire is available only to registered users. This is best for professional traders and people who track markets actively.Real-Time EquityWire is available only to registered users. This is best for professional traders and people who track markets actively.
Dr Reddy’s Laboratories Ltd is aspiring to deliver double-digit revenue growth by strengthening its core business and by investing in future growth drivers, the company said in its 2023-24 (Apr-Mar) annual report. Developing innovative products, expanding into new markets across geographies and adopting innovative growth models are key for growth, the company said.
Share this Story:
